Impact in numbers
Validated science, measurable performance, and clinical impact our AI platforms deliver results you can trust.
Salute Futura is building advanced AI platforms that transform clinical research and patient care backed by decades of medical and scientific expertise.
Schedule meetValidated science, measurable performance, and clinical impact our AI platforms deliver results you can trust.

Why invest in Salute Futura? We combine AI innovation, clinical validation, and a world-class team to transform global healthcare.
Salute Futura develops AI-powered platforms that transform clinical research and decision-making in healthcare. Built on decades of medical and academic expertise, our products address multi-billion dollar markets in precision medicine and clinical trials. With validated technology, a world-class leadership team, and a scalable business model, we are positioned to become a global player in health tech innovation.

Salute Futura was founded by leading experts who combine decades of clinical practice and AI research. Our leadership team unites medicine and technology with one mission: transforming healthcare through data-driven innovation.
Young AI researchers contributing to Salute Futura’s innovation.
AI-powered solutions designed to turn complex data into clinical intelligence ranging from broad prediction and optimization to disease-specific decision support.
An AI-driven platform that automatically selects and trains the best machine learning models to deliver accurate predictions and optimized solutions. MedPrO empowers researchers and clinicians to move from raw data to actionable insights without coding expertise.

A specialized decision-support platform that predicts the likelihood of urinary stone expulsion using patient demographics and clinical features. USEP provides instant, probabilistic outcomes to help physicians choose the most effective treatment strategy.

Get in touch with our team to explore partnerships, request a demo, or learn more about Salute Futura’s platforms.